Merlin Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $847K | Buy |
2,027
+45
| +2% | +$18.8K | 2.53% | 13 |
|
|
2023
Q4 | $806K | Sell |
1,982
-30
| -1% | -$12.2K | 2.58% | 6 |
|
|
2023
Q3 | $700K | Sell |
2,012
-29
| -1% | -$10.1K | 2.61% | 6 |
|
|
2023
Q2 | $718K | Sell |
2,041
-251
| -11% | -$88.3K | 2.43% | 12 |
|
|
2023
Q1 | $722K | Sell |
2,292
-46
| -2% | -$14.5K | 2.62% | 8 |
|
|
2022
Q4 | $675K | Sell |
2,338
-106
| -4% | -$30.6K | 1.66% | 23 |
|
|
2022
Q3 | $708K | Sell |
2,444
-369
| -13% | -$107K | 1.64% | 13 |
|
|
2022
Q2 | $793K | Sell |
2,813
-221
| -7% | -$62.3K | 1.59% | 15 |
|
|
2022
Q1 | $792K | Sell |
3,034
-947
| -24% | -$247K | 1.05% | 25 |
|
|
2021
Q4 | $874K | Buy |
+3,981
| New | +$874K | 1.01% | 30 |
|